The U.S. is facing its worst measles outbreak in over three decades, with more than 5,100 cases reported in 2026 and eight associated deaths. This resurgence is expected to lead to the loss of the country's official measles elimination status, as reviewed by the Pan American Health Organization.
A new tool from Johns Hopkins University estimates that the economic impact of this year's outbreaks could reach nearly $83 million, which includes $56 million in public health response costs, almost $25 million in lost productivity, and over $1.8 million in direct medical expenses.
The tool also indicates that the 2025 outbreaks, which had 2,289 confirmed cases, resulted in costs exceeding $37 million. The financial burden extends beyond treating the sick; it encompasses the costs of public health investigations, notifications, and vaccination campaigns, which can divert resources from other health priorities.
For instance, New York's 48 cases in 2025 incurred approximately $1.1 million in costs, while Texas's 803 cases accounted for nearly $13 million. The analysis underscores the economic ripple effects of measles, as quarantines and missed work due to exposure can lead to substantial productivity losses.
Health economist Bryan Patenaude emphasized that the findings could assist health departments in preparing for future outbreaks, especially as vaccination rates decline and the risk of further outbreaks increases